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A quantitative telomeric chromatin isolation
protocol identiﬁes different telomeric states
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Telomere composition changes during tumourigenesis, aging and in telomere syndromes in
a poorly deﬁned manner. Here we develop a quantitative telomeric chromatin isolation
protocol (QTIP) for human cells, in which chromatin is cross-linked, immunopuriﬁed and
analysed by mass spectrometry. QTIP involves stable isotope labelling by amino acids in cell
culture (SILAC) to compare and identify quantitative differences in telomere protein com-
position of cells from various states. With QTIP, we speciﬁcally enrich telomeric DNA and all
shelterin components. We validate the method characterizing changes at dysfunctional tel-
omeres, and identify and validate known, as well as novel telomere-associated polypeptides
including all THO subunits, SMCHD1 and LRIF1. We apply QTIP to long and short telomeres
and detect increased density of SMCHD1 and LRIF1 and increased association of the shel-
terins TRF1, TIN2, TPP1 and POT1 with long telomeres. Our results validate QTIP to study
telomeric states during normal development and in disease.
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T
elomeres have crucial roles as guardians of the genome and
tumour suppressors1. Telomere length shortens in the
absence of telomerase due to the end replication problem
and nucleolytic trimming of chromosome ends. Upon reaching a
critically short size, telomeres trigger cellular senescence.
Therefore, the absence of telomerase in most normal human
somatic cells limits cellular lifespan and should suppress the
growth of premalignant lesions that have lost normal cell cycle
control2. On the other hand, telomerase is expressed during early
embryogenesis and in some stem cells. This is important as
deﬁciencies in telomerase genes lead to premature telomere
shortening giving rise to degenerative syndromes with
overlapping clinical features3. Telomere syndromes comprise
dyskeratosis congenita, idiopathic pulmonary ﬁbrosis, aplastic
anaemia, Coats plus and others.
Telomere function relies on its constituents, which includes
telomeric DNA, telomeric proteins and the telomeric RNA
TERRA4,5. Telomeric DNA consists of simple repetitive DNA
sequences (50-TTAGGG-30/50-CCCTAA-30 repeats in humans) of
several kilobases and terminates with single-stranded (ss) 30
overhangs measuring a few hundred nucleotides6. Telomeric
DNA is assembled with specialized telomere-binding proteins.
The shelterin proteins include six abundant telomere-associated
proteins1. The shelterin components TRF1 and TRF2 both bind
directly to the double-stranded portion of telomeric DNA as
homodimers7. POT1 binds the telomeric 30 overhang8. TIN2,
TPP1 and RAP1 associate with telomeres through protein
interactions with TRF1, TRF2 and POT1. In senescent cells,
short telomeres activate both ATM and ATR9. This telomeric
state can be mimicked by experimental depletion of TRF2 from
telomeres, which leads to the activation of ATM and depletion of
POT1, which results in activation of ATR10.
In addition to shelterin, an increasingly large number of less
abundant and less-well characterized proteins were found in
association with telomeres. These proteins also perform crucial
functions, a fact that is underlined by the ﬁnding that they are
mutated in several fatal degenerative syndromes. Some of them
such as the Werner protein, Rtel1 and Pif1 are involved in the
semiconservative DNA replication of telomeres for example to
unwind G-quadruplex DNA structures, in which guanine bases of
the telomeric G-strand associate through Hoogsteen hydrogen
bonding to form tetrads11–14. Other important telomere factors
are involved in the regulation of telomerase.
The complete protein composition present at telomeres is not
known nor are the changes in telomeric chromatin composition
deﬁned that occur during tumourigenesis, in short telomere
syndromes and aging. Arguably one of the most important
challenges of the telomere ﬁeld is to deﬁne these changes and
characterize their function. Here, we develop a quantitative
telomeric chromatin isolation protocol (QTIP), which allows the
comprehensive determination of telomere protein composition
and the quantitative comparison of telomere protein composi-
tions between cells that have different telomeric states. We
implement QTIP to human cancer cells in which a telomeric
DNA damage response is elicited by depletion of TRF2 or POT1,
and to cancer cells with different telomere length, and we identify
polypeptides that preferentially bind to long telomeres. The
methodology developed here may also be adapted to other
chromatin regions of the genome.
Results
Implementation of QTIP. To compare telomeric chromatin
composition from cells with different telomeric states, we devel-
oped QTIP. In QTIP, the proteins in the different cell populations
to be compared are differentially labelled by incubating the cells
in medium containing either heavy isotopes ([13C6 15N4]Arg
(R10) and [13C6 15N2]Lys (K8)) or light isotopes (Arg (R0) and
Lys (K0)) (Approach A, Fig. 1a). Cells are mixed in a 1:1 ratio,
chromatin is cross-linked with formaldehyde and sonicated upon
cell lysis to obtain chromatin particles with DNA fragments of an
average size of 200 bp (Approach A, Fig. 1a). Telomeric chro-
matin is puriﬁed from the chromatin fraction by immunopreci-
pitation using afﬁnity-puriﬁed polyclonal rabbit antibodies that
were raised against full-length recombinant TRF1 and TRF2 and
were covalently cross-linked to Protein G Sepharose beads.
Independent batches of self-raised antibodies and also commer-
cial antibodies were tested and found suitable for telomeric
chromatin puriﬁcation (Supplementary Fig. S1). After extensive
washing, puriﬁed material is eluted, the cross-links are reversed
and proteins are fractionated by SDS–PAGE, trypsin digested and
analysed by liquid chromatography–mass spectrometry (LC-MS/
MS). The control experiment with unspeciﬁc immunoglobulin G
(IgG) can be performed either in parallel on the same mixed cell
population (Approach A, Fig. 1a) or a separate immunoprecipi-
tation can be performed on cells grown in a third stable isotope
labelling by amino acids in cell culture (SILAC) medium
(Approach B, Fig. 1a). Thus in approach B, a triple SILAC
strategy is employed which allows quantitative comparison of IgG
contaminants by LC-MS/MS. This is optimal for the identiﬁca-
tion of new telomere interacting factors and their distinction from
potential contaminants15. Approach A, on the other hand,
minimizes experimental variations between the two samples
and is suitable to compare variations of protein levels at telomeres
between two different conditions.
We ﬁrst determined which telomeric proteins are identiﬁed by
QTIP in HeLa cells. The yield of telomeric DNA in QTIP samples
was quantiﬁed by dot blot hybridization with a 32P-labelled
telomeric probe and compared with the signal with a probe
against Alu-repeat DNA (Fig. 1b,c). Typically, 3–20% of telomeric
DNA was recovered with a several hundred-fold enrichment over
Alu-repeat DNA. QTIP using negative control IgG antibody did
not give a detectable telomeric DNA signal (Fig. 1b,c). In QTIP
puriﬁcations with antibodies against TRF1, TRF2 or a mixture
thereof, we consistently identiﬁed peptides corresponding to all
six shelterin components (Table 1). None of the shelterin
components was identiﬁed with negative control IgG. In addition,
we identiﬁed peptides from several other reported telomere-
associated components and factors known to assemble with
telomere-associated components (Supplementary Table S1). This
includes the telomere end processing enzymes Apollo, Mre11,
Nbs1 and Rad50; ORC complex components, DNA polymerase d,
the WRN interacting protein WRNIP1, which is required for
efﬁcient telomere replication13; PNUTS16 and subunits of the
PNUTS containing PTW/PP1 phosphatase complex, which had
not been previously characterized at telomeres17.
Identiﬁcation of the THO complex at telomeres. In addition to
the factors listed in Table 1 and Supplementary Table S1, we
identiﬁed peptides from seven of the eight subunits of the THO
and TREX complexes, LRIF1 and SMCHD1 (described below) at
telomeres (Table 2). THO has roles in mRNP biogenesis, con-
necting transcription elongation with RNA maturation and
nuclear export, and preventing genetic instability18. Its function
in the regulation of the long noncoding RNA TERRA at
telomeres and telomere stability in Saccharomyces cerevisiae is
characterized in a separate paper19. We validated the presence of
the human Thoc1 subunit at telomeres in chromatin
immunoprecipitation (ChIP) experiments with an antibody
(Fig. 2a,b). Dot blot hybridization demonstrated speciﬁc
enrichment of telomeric DNA over Alu-repeat DNA, when
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compared with negative control IgG. To control for speciﬁcity of
the anti-Thoc1 antibody, we depleted Thoc1 by small hairpin
RNA (shRNA) and observed reduced Thoc1 levels on western
blots (Fig. 2c). Thoc1 depletion also led to an increase in g-H2AX
as expected, which is a marker for damaged DNA that
accumulates in Thoc1-depleted cells20. Importantly, Thoc1
depletion also led to a signiﬁcant reduction of the telomeric
DNA signal in the ChIP experiments conﬁrming the signiﬁcance
of the results (Fig. 2b). Additional polypeptides that were
identiﬁed by QTIP but that are not yet validated as genuine
telomere components by independent experiments can be
accessed online (Supplementary Data 1).
QTIP reveals protein changes at dysfunctional telomeres. As
mentioned in the introduction, both depletion of the double-
stranded telomeric DNA binding factor TRF2 and the ss DNA
binding factor POT1 induce dysfunctional telomeres, activating
ATM and ATR signalling, respectively10. We established HeLa
cell lines from which TRF2 or POT1 can be depleted by
doxycycline (dox)-inducible expression of shRNAs from lentiviral
vectors21 (Fig. 3a). In this system, expression of a fusion protein
of the strong repressor protein domain KRAB and the tetracycline
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Figure 1 | Quantitative telomeric chromatin isolation protocol. (a) Workﬂow of QTIP. Approach A: Cells derived from telomeric state A (Telo state A)
and telomeric state B (Telo state B) are cultivated in either light or heavy SILAC medium for ﬁve population doublings and then mixed in a 1:1 ratio,
cross-linked with formaldehyde, lysed and sonicated. Telomeric chromatin is immunoprecipitated with afﬁnity-puriﬁed antibodies against TRF1 and/or TRF2
or with a nonspeciﬁc control antibody (IgG). The enriched protein–DNA complexes are washed and eluted. Following the cross-link reversal, the
proteins are subjected to tryptic digestion and identiﬁed and quantiﬁed by mass spectrometry. Peptides derived from the two conditions are distinguishable
due to their mass differences. In Approach B, the immunoprecipitation with the nonspeciﬁc control antibody (IgG) is performed separately with
control cells (Telo state A) using a third SILAC medium. Before elution, the immunoprecipitated complexes of the TRF1/TRF2 and the IgG IPs are
mixed. The following steps are as in approach A (b) QTIP speciﬁcally enriches for telomeric DNA. Dot blot of DNA enriched by QTIP probed with a
telomere-speciﬁc probe (Telo) or a probe against Alu-repeat DNA (Alu). (c) Quantiﬁcation of the dot blot represented in (b). Representative result from
one QTIP experiment.
Table 1 | QTIP speciﬁcally enriches for all shelterin subunits.
Number of unique peptides identiﬁed by QTIP
TRF1/2 IP TRF1 IP TRF2 IP IgG IP
TRF1 24 23 18 0
TRF2 30 19 28 0
RAP1 33 16 33 0
TIN2 23 18 18 0
TPP1 10 8 7 0
POT1 24 20 15 0
Number of unique peptides for the six shelterin subunits identiﬁed by QTIP at short and long
telomeres are listed.
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repressor (tTR), which binds on either side of the H1 promoter
to tetO sequences, represses transcription of the shRNA in the
absence of dox. Repression is relieved upon addition of dox to
the medium, which induces a conformational change in tTR-
KRAB preventing its binding to tetO. We transduced HeLa cells
consecutively with the repressor construct and shRNA constructs.
After clonal selection using ﬂuorescence-activated cell sorting
(FACS) of dox-regulatable green ﬂuorescent protein (GFP)
expression, TRF2 knockdown was characterized in several
clones. Western blot analysis of two clones showed efﬁcient
TRF2 depletion upon addition of dox, concomitant with an
upregulation of the phosphorylated form of H2AX (g-H2AX)
indicating a DNA damage response (Fig. 3b). Furthermore,
analysis of metaphase chromosome spreads of cells induced for 5
to 7 days showed that the TRF2 knockdown induced telomere
fusions as expected for a functional depletion of this protein22
(Fig. 3d). We also veriﬁed the amount of telomeric DNA in cells
with dysfunctional telomeres, which did not vary signiﬁcantly
upon depletion of TRF2 (Supplementary Fig. S2). POT1
reduction was assessed by qRT–PCR comparing messenger
RNA levels in uninduced and induced cells (Fig. 3c). To
conﬁrm that the POT1 knockdown was activating DNA
damage signalling speciﬁcally at telomeres, we performed ChIP
with anti g-H2AX antibodies that showed enrichment of
telomeric DNA but not Alu-repeat DNA upon dox induction
(Fig. 3e). Thus, the characterized HeLa cell lines allow regulatable
telomere deprotection.
We applied QTIP to one of the HeLa cell clones in which we
could deplete TRF2 upon addition of dox. Cells were grown
for ﬁve generations in medium containing heavy isotopes ([13C6
15N4]Arg (R10) and [13C6 15N2]Lys (K8)). Dox was added
(þ dox) during the last 4 days of cultivation with heavy isotopes
to induce shRNA expression. These cells were then mixed with
equal number of uninduced ( dox) cells grown for ﬁve
doublings in medium containing medium isotopes ([13C6]]Arg
(R6) and [4,4,5,5-D4]Lys (K4)) and processed (Fig. 1a). As TRF2
had been depleted in the þ dox cells, we only used anti-TRF1
antibodies for QTIP. In parallel, an equal number of cells was
grown in light SILAC medium (Arg (R0) and Lys (K0)) and
subjected to immunoprecipitation with unspeciﬁc rabbit IgG.
Before elution, the washed beads of the TRF1 and IgG
immunoprecipitates were mixed (Fig. 1a, Approach B). Compar-
ing the ratio heavy/medium revealed changes at telomeres that
occurred upon TRF2 depletion (Fig. 4a). As expected, TRF2
strongly decreased at telomeres from þ dox cells (Fig. 4a).
Interestingly, the shelterin components TRF1, TIN2, TPP1 and
POT1 were also clearly reduced in TRF2-depleted cells suggesting
that their association with telomeres is promoted by TRF2. RAP1
was also detected at telomeres; however, the low abundance of
detected peptides did not allow quantiﬁcation. When including
the TRF1/IgG immunoprecipitation ratio performed in the scatter
plot (Fig. 4b), we observed speciﬁc enrichment of telomeric
proteins with the TRF1 antibody compared with the IgG control
(Fig. 4b). This result underlines the suitability of the triple SILAC
approach to distinguish telomeric proteins. The reproducibility of
the technique was very good as assessed by comparing two
independent QTIP experiments (Supplementary Fig. S3). In
addition to the discussed shelterins, several new candidate
proteins showed increasing or decreasing levels at telomeres
Table 2 | List of novel telomeric proteins identiﬁed by QTIP.
Number of unique peptides identiﬁed by QTIP
TRF1/2 IP IgG IP
THOC1 36 0
THOC2 49 0
THOC3 5 0
THOC4 4 3
THOC5 22 0
THOC6 17 1
THOC7 8 0
LRIF1 11 0
SMCHD1 21 2
Number of unique peptides identiﬁed in a QTIP experiment of short and long telomeres
performed with antibodies against TRF1 and TRF2 are depicted.
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Figure 2 | QTIP identiﬁes novel telomeric proteins. (a) Validation of
Thoc1 as a novel telomeric protein. ChIP against endogenous Thoc1 in HeLa
cells with short telomeres. Thoc1 ChIP in HeLa cells upon shRNA-mediated
Thoc1 knockdown was performed as a speciﬁcity control for the antibody.
ChIPed DNA was probed with a telomere-speciﬁc probe (Telo) and a
probe against Alu-repeat DNA (Alu). (b) Quantiﬁcation of Thoc1 ChIP as
shown in (b). Error bars correspond to s.d. of results of four independent
experiments (Student’s t-test, *P value o0.05, **P value o0.005). (c)
Western blot conﬁrming knockdown of Thoc1 protein and increase of
gH2AX phosphorylation upon Thoc1 knockdown.
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upon TRF2 depletion. Their putative association and biological
function at telomeres will require validation and further
characterization.
QTIP analysis was also applied to the POT1-depleted HeLa cell
clones using TRF1 and TRF2 antibodies. POT1-depleted (þ dox)
cells were grown with heavy isotopes, non-depleted ( dox) cells
with medium isotopes and the IgG control was applied to cells
grown with light isotopes. The scatter plot (Fig. 4c) revealed a
strong depletion of POT1 at telomeres from þ dox cells as
expected. In contrast to the TRF2 knockdown, POT1 depletion
was not accompanied by a concomitant decrease of the other ﬁve
shelterin components. The speciﬁc decrease of POT1 was
conﬁrmed when integrating the IgG immunoprecipitation data
in the scatter plot (Fig. 4d, Supplementary Fig. S4). This result
conﬁrms that QTIP allows precise and quantitative analysis of
changes in protein composition at telomeres.
Increased association of proteins with long telomeres. Having
validated QTIP for the identiﬁcation of changes in protein
composition at telomeres, we compared by QTIP telomeres of
different lengths. To induce telomere elongation, we stably
transduced HeLa cells with constructs for the catalytic core
components of telomerase hTERT and human telomerase RNA
as described23 and expanded the cells for B35 population
doublings. Telomere length analysis by Southern blotting (Fig. 5a)
revealed an average telomere length of B10 kb in parental HeLa
cells (termed ‘short’) and an average telomere length of 30 kb in
telomerase-transduced HeLa cells (termed ‘long’). The proteins in
the two different HeLa cell populations were differentially labelled
for ﬁve generations incubating the cells in medium containing
either heavy isotopes ([13C6 15N4]Arg (R10) and [13C6 15N2]Lys
(K8)) or light isotopes (Arg (R0) and Lys (K0)) (Fig. 1a, Approach
A). In consecutive experiments, the labelling with heavy and light
amino acids was inverted for HeLa cells with long and short
telomeres giving similar results (Fig. 5b). QTIP was performed
with a mixture of anti-TRF1 and anti-TRF2 antibodies (Fig. 5b).
Using QTIP, we recovered increased amounts of the shelterin
components TRF1, TIN2, TPP1 and POT1 from HeLa cells with
long telomeres (Fig. 5b). The increased association of POT1 and
TPP1 with long telomeres is not due to a longer ss telomeric 30
overhang, which is similar in the two cell lines (Supplementary
Fig. S5). TRF2 and RAP1 on the other hand were equally
abundant at long and short telomeres. In addition, we observed a
very strong increase of SMCHD1 (structural maintenance of
chromosomes ﬂexible hinge domain-containing protein 1) and
LRIF1 (ligand-dependent nuclear receptor-interacting factor 1) at
long telomeres (Fig. 5b). When performing QTIP in separate
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Figure 3 | Inducible TRF2 and POT1 knockdown generates dysfunctional telomeres. (a) Lentiviral vector-based strategy allowing dox-regulatable
expression of shRNAs using tTR-KRAB repressor. (b–e) Characterization of HeLa cells upon induction of TRF2 or POT1 knockdown. (b) Western blot
analysis revealing TRF2 depletion and H2AX phosphorylation after 4 days of dox induction. Asterisk: unspeciﬁc signal (two clones analysed).
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experiments with either anti-TRF1 or anti-TRF2 antibodies only,
we also observed increased amounts of LRIF1 and SMCHD1 with
long telomeres (Fig. 5c,d). LRIF1 is a nuclear protein identiﬁed in
a 2-hybrid screen with RARa. LRIF1 also interacts with histone
deacetylases24 repressing reporter gene expression. SMCHD1
localizes to the inactive X chromosome in females and has a role
in the maintenance of X inactivation and hypermethylation of
CpG islands25. Interestingly, LRIF1 (also referred to as HBiX1)
and SMCHD1 were recently shown to physically interact and
to be important for compacting H3K9me3-rich and XIST-
H3K27me3 domains at the inactive X chromosome in human
cells26.
To validate the identiﬁed changes in telomeric chromatin
composition upon telomere elongation, we performed with the
same HeLa cells additional ChIP experiments using antibodies
against selected telomere components and quantiﬁed telomeric
DNA and Alu-repeat DNA as a negative control in the ChIP
samples (Fig. 6). For TRF1, we conﬁrmed in ChIP experiments
that higher absolute amounts of TRF1 are present at telomeres
when they are long but that the relative association, reﬂecting the
density of binding is slightly reduced. Alternatively, long
telomeres may contain longer stretches devoid of TRF1 (Fig. 6a,
Supplementary Fig. S6). For TRF2, ChIP experiments indicated
an even stronger density decrease at long telomeres than for
TRF1, explaining why no difference in absolute TRF2 quantity
was detected by QTIP between long and short telomeres. This,
therefore, indicates that TRF2 density at long telomeres is lower
or that long telomeres contain larger stretches of telomeric DNA
lacking TRF2 (Fig. 6a, Supplementary Fig. S6). MRN complex
(Mre11/Rad50/Nbs1) association with functional telomeres is
mediated by TRF2 (ref. 27). Therefore, one would expect similar
results for TRF2 and Mre11 in QTIP and ChIP experiments when
comparing short and long telomeres. Indeed, as for TRF2, we did
not recover more Mre11 from cells with long telomeres. Mre11
also showed the same trend as TRF2 in the ChIP experiment,
associating with lower relative amounts of telomeric DNA at long
telomeres (Fig. 6b, Supplementary Fig. S6).
To study telomere association of LRIF1 by ChIP, we expressed
3xHA-tagged LRIF1 upon transient transfection in the HeLa cells
with long and short telomeres and performed ChIP with anti-HA
antibodies (Fig. 6c). The telomeric signal obtained with cells
expressing 3xHA-LRIF1 was signiﬁcantly higher than in cells
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Figure 4 | QTIP reveals quantitative changes in protein composition at dysfunctional telomeres. (a) Scatter plot representing the log2 ratio of
a QTIP experiment with cells depleted for TRF2 versus uninduced control cells (wild type, wt). The signiﬁcances of variations are indicated (top right).
(b) Comparison of log2 ratio (TRF2 kd/wt) to log2 ratio of TRF1 versus IgG immunoprecipitation in wt. Proteins present at telomeres in wt condition
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expressing the empty vector control (3xHA). Strikingly, the
immunopuriﬁcation yielded higher levels of telomeric DNA from
long telomeres not only in absolute but also relative amounts. This
result is consistent with the QTIP analysis (Fig. 5) supporting the
notion that LRIF1 preferentially binds to long telomeres (Fig. 6c,
Supplementary Fig. S6). For SMCHD1, we performed ChIP using
antibodies against the endogenous protein (Fig. 6d). Telomeric
DNA was speciﬁcally enriched when compared with the signal
obtained with nonspeciﬁc control antibodies (IgG). Furthermore,
small interfering RNA (siRNA)-mediated depletion of SMCHD1
(Fig. 6e) led to a decrease of the telomeric signal, indicating
speciﬁcity of the antibody for SMCHD1. As seen for LRIF1,
immunopuriﬁcation of SMCHD1 yielded more telomeric DNA in
absolute and relative amounts from long telomeres conﬁrming the
conclusion from the QTIP experiment that SMCHD1 preferen-
tially associates with long telomeres (Fig. 6d, Supplementary Fig.
S6). We tested on western blots of whole cell lysates, whether
telomere length had an impact on protein abundance of the
factors under investigation (Fig. 6f–h). However, TRF1, TRF2,
Mre11, SMCHD1 and 3xHA-LRIF1 levels did not change
signiﬁcantly upon telomere elongation. Therefore, the differences
seen in telomere association with long and short telomeres are not
due to changes in protein abundance.
Discussion
One of the biggest challenges in the telomere ﬁeld is to identify
the molecular changes at telomeres that occur in cancer and in
telomere syndromes. With QTIP, we develop here a method that
allows puriﬁcation of telomeric chromatin and its analysis by
mass spectrometry. We apply QTIP to cells with different
telomeric states, including dysfunctional telomeres or telomeres
with various lengths, and we demonstrate that QTIP is suitable to
identify quantitative differences between diverse telomeric states.
A method termed PICh in which telomeres are partially
denatured and afﬁnity puriﬁed via antisense hybridization
techniques was described before28. In both, QTIP and PICh,
telomeric chromatin is cross-linked in vivo and subsequently
puriﬁed. Therefore, both methods represent a signiﬁcant advance
over attempts to study telomeric chromatin upon reconstitution
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Figure 5 | Identiﬁcation of quantitative differences between telomeric proteins at short and long telomeres by QTIP. (a) Telomere restriction analysis
of isogenic Hela cells with short or long telomeres used for QTIP experiments. (b) Scatter plot representing the log2 (ratio long/short) from two
independent biological TRF1/2 QTIP experiments. Proteins signiﬁcantly changing between short and long telomeres in both experiments are indicated
by a green dot, whereas factors that are not changing are represented by a grey dot (for example, THO complex subunits). (c) Intensities versus log2
(ratio long/short) of a TRF1 QTIP experiment are depicted. (d) Intensities versus log2 (ratio long/short) of a TRF2 QTIP experiment are depicted.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3848 ARTICLE
NATURE COMMUNICATIONS | 4:2848 | DOI: 10.1038/ncomms3848 | www.nature.com/naturecommunications 7
& 2013 Macmillan Publishers Limited. All rights reserved.
in vitro. However, QTIP and PICh have the following signiﬁcant
differences. PICh includes an RNase step, which may lead to the
loss of TERRA-dependent telomeric factors. This may explain
why PICh did not identify subunits of the THO/TREX complexes
except THOC4. Additionally, PICh requires 60 higher cell
numbers than QTIP. Most signiﬁcantly, QTIP uses the SILAC
methodology and allows quantitative comparison of telomeric
states of different cells. Both methods identiﬁed all shelterin
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components but for telomere-associated proteins, there is only a
partial overlap (Supplementary Data 1 and Supplementary Fig. S7).
Thus, both methods provide complementary information.
We identify by QTIP seven THO/TREX subunits at telomeres
and we validate telomere association of Thoc1 by ChIP. The THO
complex is involved in RNA maturation18 and its presence at
telomeres suggests roles in TERRA biogenesis. We were so far
unable to conﬁrm this notion for human TERRA but our
laboratory has recently obtained data in S. cerevisiae, which
demonstrate that telomere association of THO is conserved in
yeast and that THO removes DNA–RNA hybrids from yeast
telomeres19.
The QTIP experiments performed with cells depleted for TRF2
or POT1 demonstrate that we can identify quantitative changes of
the target telomeric protein and the effect of the knockdown on
the protein complex partners. Additionally, we identiﬁed several
new candidate telomere proteins, which were enriched in the
TRF1/2-QTIP over the IgG control at wt telomeres and whose
abundance changed at telomeres upon TRF2 or POT1 depletion.
These proteins will require individual validation and
characterization.
We also discover using QTIP that LRIF1 and SMCHD1
preferentially associate with long telomeres. These results were
conﬁrmed in ChIP experiments, which further indicated an
increased density for both of these factors at long telomeres.
SMCHD1 is also associated with the inactive X chromosome
sustaining methylation of CpG island25 and X chromosome
compaction26. A similar function at telomeres might contribute
to the preferential silencing of CpG island containing TERRA
promoters at long telomeres29,30. As LRIF1 has been reported to
interact with histone deacetylases24, it might also reinforce the
heterochromatic nature of long telomeres. A role in telomeric
heterochromatin is also consistent with the recent observation of
its interaction with SMCHD1 (ref. 26). We also identify using
QTIP differences for shelterin components at long and short
telomeres. With long telomeres, we recovered more TRF1, TIN2,
TPP1 and POT1 by QTIP. For TRF1, we conﬁrmed in ChIP
experiments that higher absolute amounts of TRF1 are present at
telomeres when they are long but that the relative association and
therefore the density of binding is reduced. Alternatively, long
telomeres may contain longer stretches that lack TRF1. For TRF2,
the ChIP experiments indicated that the difference in density at
long telomeres drops more substantially than for TRF1 explaining
why no difference was detected for TRF2 by QTIP between long
and short telomeres. Our results therefore reinforce the notion
that shelterin may exist at telomeres not only as a six-subunit
complex but that shelterin sub-complexes of various composition
may associate with chromosome ends. Shelterin sub-complexes
have been seen in previous studies in nuclear extracts31–33 and
absolute quantiﬁcations of shelterin components in cells
demonstrated that they are not stoichiometric34. Future work
will try to elucidate the function of SMCHD1 and LRIF1 at long
telomeres and validate telomere association of other identiﬁed
candidates. We anticipate that QTIP may ﬁnd broad and useful
applications for the diagnosis and characterization of cancer
types, telomere syndromes and for addressing how telomeric
chromatin composition may change during development. More
generally, our approach might be applicable to other chromatin-
interacting complexes such as chromatin modiﬁers or
transcription factors to study composition and modular changes
of a variety of chromatin-associated complexes.
Methods
Cell culture and transfections. HeLa super-telomerase and HeLa control cells
were generated by transducing HeLa cells (ATCC) with retroviruses expressing
hTERT from the LTR (long terminal repeat) promoter and human telomerase
RNA from the U1 promoter or with empty vectors, respectively23. For Thoc1
shRNA knockdown and LRIF1 expression, cells were transfected with
Lipofectamine 2000 (Invitrogen). shRNA-transfected cells were selected with
puromycin (1 mgml 1, InvivoGen) starting 24 h after transfection during 4 days.
Thoc1 ChIP experiments were performed 5 days after transfection. LRIF1 ChIP
experiments were performed 48 h after transfection. For SMCHD1 siRNA KD, cells
were transfected with INTERFERin (Polyplus) and with siRNA against SMCHD1
(Hs_KIAA0650_3, Qiagen) or a negative control siRNA (AllStars Negative Control
siRNA, Qiagen). SMCHD1 ChIP experiments were performed 48 h post
transfection.
The inducible cell lines were generated by infection of HeLa cells with second-
generation lentiviral vectors containing the tTR-KRAB construct and dsRED
marker. Subsequently, cells were infected with the second lentiviral vector
containing the H1 promoter-controlled shRNA sequence and GFP marker.
FACS allowed selection of single cells and establishment of clonal populations.
Inducible cell lines were grown in Dulbecco’s Modiﬁed Eagle Medium (DMEM)
supplemented with 10% Tet System Approved FBS (Clontech), 100Uml 1
penicillin and 100mgml 1 streptomycin (Gibco). Dox was used at 1 mgml 1
for induction.
SILAC labelling was performed by cultivating cells for ﬁve population doublings
in SILAC DMEM supplemented with 10% dialysed FCS, 100Uml 1 penicillin
and 100 mgml 1 streptomycin (Gibco), 25mg l 1 arginine (light arg: 12C/14N,
medium arg: 13C or heavy arg: 13C/15N), 46mg l 1 lysine (light lys: 12C/14N,
medium lys: D or heavy lys: 13C/15N) and 200mg l 1 Proline. SILAC reagents
were from the Thermo Fisher Scientiﬁc group with the exception of heavy and
medium arginine and lysine (Cambridge Isotopes Laboratories). In the forward
experiment, HeLa control cells were labelled with light amino-acid sets. In the
reverse experiment, they were labelled with heavy amino acids.
Lentiviral vectors production and cell transduction. Lentiviral vectors were
produced21. Plasmids pMD2G (55 mg), pCMVR8.74 (102 mg) and pLV-tTR-KRAB-
red or pLV-T derivatives, to express shRNA sequences (157 mg) (kind gifts from
Didier Trono), were mixed for co-transfection of HEK293T cells on 7 150mm
dishes using the calcium phosphate method (CalPhos Mammalian Transfection
Kit, Clontech). Cells were incubated overnight and the supernatant was replaced
by fresh DMEM medium containing 10% FCS. Supernatant was collected after 8 h
and replaced by fresh medium for another 12 h. The harvested supernatant was
cleared using a 0.22 mm ﬁlter unit (Stericup, Millipore) before concentration by
ultracentrifugation for 2 h at 50,000 g, 16 C (Beckman Coulter: Ultra-Clear tubes
No. 344058, Rotor SW32Ti). The pellets were resuspended in a minimal volume of
cold phosphate-buffered saline (PBS) and the lentiviral particles frozen at  80 C.
HCT116 cells were used for determination of lentiviral vector titre by FACS
analysis of GFP or dsRED ﬂuorescence performed 3 days post transduction.
Subsequently, HeLa cells were infected with highly concentrated lentivirus using
increasing multiplicities of infection ranging from 1–100.
Expression of recombinant TRF1 and TRF2. Recombinant 6xHis-S-TRF1 and
6xHis-S-TRF2 were expressed in Rosetta DE3 pLysS competent cells (Novagen,
70956-4) from a pET-30a(þ ) plasmid (kind gifts from Daniela Rhodes). The
recombinant proteins were puriﬁed on Ni-NTA agarose (Qiagen), dialysed against
1 PBS, 10% glycerol (SnakeSkin Pleated Dialysis Tubing, 10 kDa, Thermo Fisher
Scientiﬁc Group) and concentrated in an Amicon Ultra (30 kDa, Merck-Millipore).
Antisera production against TRF1 and TRF2. Rabbits were immunized using
four injections during an 87-day programme (Eurogentec). For each injection,
120 mg of native recombinant TRF1 or TRF2 were used. Antisera from ﬁnal bleed
were used for puriﬁcation of the antibodies.
Afﬁnity puriﬁcation of TRF1 and TRF2 sera. Five milligrams of recombinant
6xHis-S-TRF1 or 6xHis-S-TRF2 protein (expressed in Rosetta DE3 pLysS com-
petent cells (Novagen, 70956-4)) was bound to 1ml Afﬁgel-10 (TRF2) or Afﬁgel-15
(TRF1) (Bio-Rad). Five millilitres of serum (TRF1 #605 448, TRF2 #605 782) was
incubated with the Afﬁgel matrix at 4 C for 3 h. Unbound antibodies were drained
and saved on ice. Bound antibodies were washed with 4ml 2 PBS and eluted
10 times with 1ml 0.2M glycine pH 2.5, 0.5M NaCl. The eluted antibodies were
immediately neutralized with saturated Tris base. The Afﬁgel matrix was regen-
erated by washing with 2ml 2 PBS and the serum was loaded onto the matrix a
second time. The following steps were performed as above. Antibody containing
fractions were pooled, dialysed against 1 PBS, 8.7% glycerol (SnakeSkin Pleated
Dialysis Tubing, 10 kDa, Thermo Fisher Scientiﬁc Group) and concentrated in an
Amicon Ultra (30 kDa, Merck-Millipore).
Dimethyl Pimelimidate coupling of anti-TRF1 and anti-TRF2 to Protein G
Sepharose. Afﬁnity-puriﬁed anti-TRF1 or anti-TRF2 were incubated for 1 h at
room temperature with Protein G Sepharose 4 Fast Flow (GE Healthcare Life
Sciences). The sepharose was washed once with 10 volumes 1 PBS and twice
with 10 volumes 0.2M sodium borate pH 9.0. 20mM dimethyl pimelimidate
(DMP-solid, Sigma-Aldrich) was added to the sepharose resuspended in 10
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volumes 0.2M sodium borate pH 9.0. After 30min at room temperature, the
reaction was stopped by washing the sepharose twice with 10 volumes of 0.2M
ethanolamine pH 8.0. The sepharose was incubated for an additional 2 h in 10
volumes 0.2M ethanolamine at room temperature, washed extensively with 1
PBS and resuspended in 1 volume of ChIP dilution buffer.
QTIP. In approach A, equal amounts of HeLa control and HeLa super-telomerase
cells grown in either light or heavy SILAC medium were mixed in a 1:1 ratio. Cells
were washed twice in PBS and cross-linked in 1% formaldehyde-1 PBS for 15min
at 30 C. Glycine (pH 2.5) was added to 125mM in order to quench the reaction
before washing the cells twice with PBS. Cells were lysed in lysis buffer (1% SDS,
10mM EDTA pH 8.0, 50mM Tris pH 8.0, EDTA-free protease inhibitor complex
(Roche)) and incubated for 5min at room temperature, centrifuged for 5min at
1,500 g, washed once in lysis buffer and centrifuged as above. The chromatin-enriched
pellets were resuspended in lysis buffer and sonicated during 30 cycles with 30 s ON
and 30 s OFF per cycle using a Bioruptor (Diagenode, Twin, High Energy setting) or
30min using a Focused-Ultrasonicator (E220, Covaris, duty: 5.0, PIP: 140, cycles: 200,
amplitude: 0, velocity: 0, dwell: 0, 12 12-mm glass tubes with AFA ﬁbre) replacing
SDS in lysis buffer by 0.1% Na-deoxycholate, 0.25% sodium lauroyl sarcosinate. The
sonicated lysate was centrifuged at 4 C for 15min at 20,000 g. The supernatant was
diluted in 2 volumes of ChIP dilution buffer (0.75% Triton X-100, 10mM EDTA pH
8.0, 50mM Tris-HCl pH 8.0, 600mM NaCl) and precleared for 1 h at 8 C with
Protein G Sepharose 4 Fast Flow (GE Healthcare Life Sciences). The precleared lysate
(corresponding to 1 108 mixed cells, 5 107 cells per condition) was incubated with
either afﬁnity-puriﬁed TRF1 (rabbit serum 448), TRF2 (rabbit serum 782), TRF1 and
TRF2 or normal rabbit IgG (sc-2027, Santa Cruz Biotechnology), using 175–230mg of
combined TRF1/TRF2 antibody and normal rabbit IgG (optimal amount determined
by titration for telomeric DNA recovery efﬁciency), covalently coupled to Protein G
Sepharose 4 Fast Flow with DMP (Sigma-Aldrich). The ChIP was performed at 8 C
overnight. Beads were washed with wash buffer 1 (0.1% SDS, 1% Triton X-100, 2mM
EDTA pH 8.0, 20mM Tris pH 8.0, 300mM NaCl), wash buffer 2 (0.1% SDS, 1%
Triton X-100, 2mM EDTA pH 8.0, 20mM Tris pH 8.0, 500mMNaCl), wash buffer 3
(500mM LiCl, 1% NP-40, 1% Na-deoxycholate, 1mM EDTA, 10mM Tris pH 8.0)
and twice with wash buffer 4 (1mM EDTA, 10mM Tris pH 8.0). DNA–protein
complexes were eluted with 2.5 bead volumes of 0.5 M NH4OH at 37 C. The eluates
were vacuum-dried in a speed vac, resuspended in Laemmli buffer, and cross-links
were reversed for 25min at 95 C. The material was separated on a 10% Mini Protean
TGX (Bio-Rad) and stained with Simply Blue Safe Stain (Invitrogen).
In approach B, cells from conditions A and B were grown in heavy and medium
SILAC medium and mixed in a 1:1 ratio for TRF1/TRF2 ChIP similarly to
approach A. Control cells, grown in light SILAC medium were processed in parallel
and used for rabbit normal IgG ChIP. After overnight incubations, beads were
washed separately as described above and beads from TRF1/TRF2 ChIP and
normal IgG were combined at the end of wash 4 for a common elution step as
described for approach A.
Plasmids. The Thoc1 shRNA vector was generated by cloning the targeting
double-stranded DNA oligonucleotides into pSUPER-Puro35 digested with BglII
and HindIII, using the following 19 nucleotides target sequence: 50-GGAAGA
TAATGATGCTCTA-30 . The coding sequence of human LRIF1 was cloned from
HeLa cDNA and inserted into a pCDNA6-3xHA vector backbone (Invitrogen)
using the In-Fusion HD cloning kit (Clontech). A cassette containing an H1
promoter sequence and the TRF2 shRNA sequence 50-GCGCATGACAATAAG
CAGA-30 or the POT1 shRNA sequence 50-GCTATCTGCTACAATACTT-30
were excised from shRNA vector construct described above and cloned into a
pLV-T-derived vector using the EcoRI and SalI restriction sites.
Telomere restriction fragment analysis and G-overhang analysis. For telomere
restriction fragment analysis and telomeric G-overhang analysis, genomic DNA
was isolated using the Wizard Genomic DNA Puriﬁcation Kit (Promega). RsaI and
HinfI restriction-digested DNA was separated by pulse-ﬁeld gel electrophoresis on
1% agarose in 0.5  TBE at 5 V cm 1 for 16 h at 14 C with switch times ramped
from 0.5 to 6 s. Telomeric DNA was denatured and detected by in-gel hybridiza-
tion23. For G-overhang analysis, genomic DNA was or was not treated with ExoI
(40U ExoI/4 mg DNA, overnight at 37 C). Following phenol extraction and
ethanol precipitation, genomic DNA was digested with RsaI and HinfI and
resolved by pulse-ﬁeld electrophoresis as described above for 14 h. For G-overhang
analysis, the gel was dried (50 C) and ﬁrst hybridized under native conditions
(50 C) for detection of ss telomeric DNA, before denaturation and a second
hybridization for total telomeric DNA. The 32P-labelled telomeric DNA probe was
prepared as for ChIP analysis (see below). For washes, the gel was rinsed in 4
SSC and incubated for 30min in 4 SSC at room temperature, followed by
successive 30min washes at 50 C in 4 SSC/0.5% SDS and 2 SSC/0.5% SDS.
Metaphase spreads analysis. Following dox induction, cells were harvested and
processed for metaphase spreads and ﬂuorescent in situ hybridization as previously
described using a Cy3-OO-(CCCTAA)3 probe and 40 ,6-diamidino-2-phenylindole
staining4.
RNA isolation and qRT–PCR. Total RNA was isolated using the NucleoSpin RNA
II kit (Macherey-Nagel) including a DNase digestion step on the column. For
reverse transcription, 1 mg RNA and random primers were used with SuperScript
III Reverse Transcriptase according to instructions (Invitrogen, Life Technologies).
For real-time PCR, we used the Power SYBR Green Mix (Applied Biosystems) and
the Applied Biosystems 7900HT Real-Time PCR System following standard pro-
cedures. Oligonucleotides sequences were: 50-TCAGTCTGTTAAACTTCATTG
CCC-30 (POT1, forward), 50-TGCACCATCCTGAAAAATTATATCC-30 (POT1,
reverse), 50-TCCCTGGAGAAGAGCTACGA-30 (b-actin, forward), 50-AGCACTG
TGTTGGCGTACAG -30 (b-actin, reverse).
In-gel digestion and LC-MS/MS. Entire lanes of SDS–PAGE gels were sliced into
pieces. The gel pieces were ﬁrst washed twice for 20min in 50% ethanol, 50mM
ammonium bicarbonate (AB, Sigma-Aldrich) and dried down by vacuum cen-
trifugation. Sample reduction was then performed with 10mM dithioerythritol
(DTE, Merck-Millipore) at 56 C for 1 h. A washing–drying step was performed as
described above before alkylation of samples with 55mM iodoacetamide (IAA,
Sigma-Aldrich) for 45min at 37 C protected from light. Samples were then
washed and dried again before storing them on ice. Digestion was performed
overnight at 37 C using modiﬁed mass spectrometry grade trypsin (Trypsin Gold,
Promega) at a concentration of 12.5 ng ml 1 in 50mM AB and 10mM CaCl2.
Resulting peptides were extracted twice for 20min in 70% ethanol, 5% formic acid
(FA, Merck-Millipore) with permanent shaking. Finally, samples were dried down
by vacuum centrifugation and stored at  20 C until LC-MS/MS measurements.
Extracted peptides were resuspended in 2% acetonitrile (ACN, Biosolve), 0.1%
FA for LC-MS/MS injections. Nano ﬂow separations were performed on a Dionex
Ultimate 3000 RSLC nano UPLC system (Thermo Fisher Scientiﬁc) on line
connected with an Orbitrap Elite Mass Spectrometer (Thermo Fisher Scientiﬁc)
piloted with Xcalibur (version 2.1) and Tune (version 2.5.5). A home-made
capillary precolumn (Magic AQ C18; 3 mm-200Å; 2 cm 100 mm ID) was used for
sample trapping and cleaning. Analytical separation was then performed using a
C18 capillary column (Nikkyo Technos; Magic AQ C18; 3 mm-100Å; 15 cm 75
mm ID) at 250 nlmin 1. Samples were separated over a 130-min biphasic gradient
ranging from 1.98% ACN, 0.099% FA (aqueous) to 81% ACN, 0.09% FA (organic).
Each sample was injected in duplicates and analysed using a data-dependent
acquisition mode with a dynamic exclusion of 40 s. The thirty most intense parent
ions from each MS survey scan (m/z 300–1,800) were selected for subsequent linear
ion trap tandem mass spectrometry (MS/MS) fragmentations by CID (Collision
Induced Dissociation). Orbitrap MS survey scans resolution was set at 60,000 (at
400m/z) and fragments were measured at low resolution into the Linear Ion Trap.
A threshold of 500 counts was applied to trigger the fragmentation and singly
charged ions were excluded. Source and fragmentation parameters were set as
follow: capillary voltage 1.9 kV; capillary temperature 240 C; normalized collision
energy, 35%; activation Q, 0.25; activation time, 10ms.
Assigning peptide sequences using Andromeda. SILAC labelled data were
analysed with MaxQuant version 1.2.2.5 and 1.3.0.5 against the UniProt human
database release 2012_04 (86747 sequences). MaxQuant generates a concatenated
decoy database complemented with common contaminant sequences to determine
the false discovery rate and to exclude false positive hits. Mass spectra were sear-
ched with an initial mass tolerance of 7 p.p.m. in MS mode and 0.5 kDa in MS/MS
mode. Up to two missed cleavages were allowed. Carbamidomethylation was set as
a ﬁxed modiﬁcation, whereas oxidation (M) and acetylation (protein N-term) (and
phosphorylation (STY) only in the approach B) were considered as variable
modiﬁcations. The minimal peptide length was set to six amino acids (seven in
MaxQuant 1.3.0.5) and at least two (uniqueþ razor) peptides were required for
protein identiﬁcation. A cut-off was ﬁxed at 1% DR at the peptide and protein level.
Reverse and contaminant sequences were removed and proteins with a posterior
error probability lower than 0.1 were accepted for further data treatment. Protein
quantiﬁcation was performed with razor and unique peptides, using only unmo-
diﬁed, oxidated (M) and acetylated (protein N-term) peptides. A minimum of two
ratio counts was required to quantify proteins.
Data analysis. SILAC ratios determined using MaxQuant were further processed
to assess the signiﬁcance of outlier ratios using Perseus, the statistical tool inte-
grated in the MaxQuant software suite36. For our data set, we report signiﬁcant
ratios based on signiﬁcance B with a Benjamin–Hochberg corrected P value
threshold of 0.05. Further statistical treatments and graphical displays were
performed using home-made programs written in R (http://www.r-project.org/).
To facilitate the comparison of the relative merits of QTIP versus the previously
established PICh28, the list of proteins identiﬁed using approach A (Supplementary
Data 1) was rank sorted in the same way as done by De´jardin and Kingston28 with
slight modiﬁcations. Brieﬂy, the ratio between telomeric or unspeciﬁcally bound
proteins was calculated by dividing the number of razor and unique peptides
identiﬁed per protein in each telomeric immunoprecipitation (TRF1, TRF2, TRF1/
2 IPs) by those identiﬁed in the control immunoprecipitation (IgG IPs). This
reﬂects the enrichment in telomeric IP. In case of no identiﬁcation in one or the
other condition, the value 0 was replaced by 0.059 (ratio between the number of
peptides of the protein of the list generating the largest number of razor and unique
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peptides to the total number of proteins identiﬁed within the whole sample).
Proteins were sorted according to this calculated ratio from high to low. Only
proteins with a ratio above 2 were considered. The list was ﬁnally ranked using the
calculated ratio of number of peptides per protein to the protein size as done by
De´jardin and Kingston28. Proteins with less than ﬁve unique/razor peptides were
not considered.
ChIP. ChIP for Mre11, TRF1, TRF2, HA, SMCHD1 and g-H2AX was performed
by preparing a chromatin-enriched extract as in QTIP. The sonicated lysate was
diluted with four volumes of IP dilution buffer (1.2mM EDTA pH 8.0, 1.1% Triton
X-100, 16.7mM Tris pH 8.0, 300mM NaCl) and incubated with the corresponding
antibody: 2 mg anti-Thoc1 (GTX118740, Genetex), 3 ml Mre11 (NB100-142, Novus
Biologicals), 20ml rabbit anti-TRF1 serum 488, 20 ml of rabbit anti-TRF2 serum
782, 2.3 mg anti-HA (AB9110, Abcam), 4 mg anti-g-H2AX (Millipore 05–636),
3 mg anti-SMCHD1 (A302-871A, Bethyl Laboratories), corresponding amount of
normal rabbit or mouse IgG (sc-2027 or sc-2025, Santa Cruz Biotechnology) and
20ml of Protein G Sepharose 4 Fast Flow at 4 C overnight. Beads were washed as
in the QTIP. Elution and cross-link reversal was performed at 65 C overnight in
1% SDS, 0.1 M NaHCO3, 0.5mM EDTA pH 8.0, 20mM Tris pH 8.0, 10 mg
DNase-free RNase (Roche). For DNA extraction, the QIAquick PCR Puriﬁcation
kit (Qiagen) was used. Telomeric and Alu-repeat DNA were detected succes-
sively37. Telomeric DNA was detected using a probe4 that was generated as follows:
a template mixture of 1–5 kb long telomeric DNA fragments was synthesized by
ligating double-stranded telomeric DNA oligonucleotides ((TTAGGG)5,
(CCCTAA)5) that were ampliﬁed by PCR. The probe was random primer labelled
with a-32P-dCTP and cold dTTP and dATP (for detection of the TTAGGG
strand). Alu-repeat DNA was detected using a 50 32P-labelled oligonucleotide probe
(50-GTGATCCGCCCGCCTCGGCCTCCCAAAGTG-30) that was hybridized at
55 C. ChIP with Thoc1 antibody was performed by preparing a chromatin-
enriched extract as above. After the sonication step, 200mM KCl was added to
precipitate the SDS. After 5min incubation on ice, the lysate was centrifuged at
4 C for 15min at 20,000 g. The supernatant was supplemented with 0.5% NP-40,
2 mg anti-Thoc1 (GTX118740, Genetex) or corresponding amount of normal rabbit
IgG (sc-2027, Santa Cruz Biotechnology) and 20 ml of protein G sepharose 4 Fast
Flow and incubated at 4 C overnight. Beads were washed ﬁve times in RLN buffer
(140mM NaCl, 50mM Tris pH 8, 1.5mM MgCl2, 0.5% NP-40). The following
steps were performed as described above.
Immunoblots. 0.5–1 105 cells were boiled for 5min in Laemmli buffer and
separated on a 4–20% Mini Protean TGX (Bio-Rad). Standard immunoblot pro-
tocols were used with the following antibodies: anti-Thoc1 (GTX118740, Genetex,
diluted 1/1,000), anti-HA (AB9110, Abcam, diluted 1:1,000), anti-g-H2AX (Mil-
lipore 05–636, diluted 1:1,000), anti-tubulin (T9026, Sigma-Aldrich, diluted
1:1,000), anti-Mre11 (NB100-142, Novus Biologicals, diluted 1/1,000), anti-TRF1
(T1948, Sigma-Aldrich, diluted 1:1,000), anti-TRF2 (05–521, Merck-Millipore,
diluted 1:1,000) anti-SMCHD1 (A302-871A, Bethyl Laboratories, diluted 1/2,000),
anti-actin (sc-1616, Santa Cruz Biotechnology, diluted 1/1,000). Secondary HRP-
conjugated antibodies against rabbit (W4011, Promega, diluted 1:3,000), mouse
(W4021, Promega, diluted 1:3,000) or goat (sc-2953, Santa Cruz Biotechnology,
diluted 1:3,000) IgG were used to reveal the primary antibodies. Luminata Forte
Western HRP Substrate (Merck-Millipore) was used for signal detection. Valida-
tion of the anti-SMCHD1 antibody is shown in Supplementary Fig. S8.
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